{"id":8505,"date":"2024-01-23T09:30:34","date_gmt":"2024-01-23T00:30:34","guid":{"rendered":"https:\/\/rakuten-med.com\/jp\/?post_type=press_releases&p=8505"},"modified":"2024-01-23T09:32:49","modified_gmt":"2024-01-23T00:32:49","slug":"%e3%82%a4%e3%83%b3%e3%83%89%e9%a0%ad%e9%a0%b8%e9%83%a8%e8%85%ab%e7%98%8d%e5%ad%a6%e4%bc%9a%ef%bc%88fhno-2023%ef%bc%89%e3%81%a7%e3%82%a2%e3%83%ab%e3%83%9f%e3%83%8e%e3%83%83%e3%82%af%e3%82%b9%e6%b2%bb","status":"publish","type":"press_releases","link":"https:\/\/rakuten-med.com\/jp\/news\/press-releases\/2024\/01\/23\/8505\/","title":{"rendered":"\u30a4\u30f3\u30c9\u982d\u9838\u90e8\u816b\u760d\u5b66\u4f1a\uff08FHNO 2023\uff09\u3067\u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u6cbb\u7642\uff08\u5149\u514d\u75ab\u7642\u6cd5\uff09\u306b\u95a2\u3059\u308b\u4e09\u3064\u306e\u62db\u5f85\u8b1b\u6f14"},"content":{"rendered":"
\n
\n\t

- \u5b9f\u81e8\u5e8a\u304a\u3088\u3073\u975e\u81e8\u5e8a\u3067\u306e\u77e5\u898b\u304c\u3001\u30a4\u30f3\u30c9\u6700\u5927\u306e\u982d\u9838\u90e8\u9818\u57df\u306e\u5b66\u4f1a\u3067\u767a\u8868\u3055\u308c\u305f<\/i><\/b><\/p>\n

\u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u793e\uff08\u672c\u793e\uff1a\u7c73\u56fd \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde \u30b5\u30f3\u30c7\u30a3\u30a8\u30b4\uff0f\u4ee5\u4e0b\u3001\u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\uff09\u306f\u30012023\u5e7412\u670822\u65e5\uff5e24\u65e5\u306b\u30a4\u30f3\u30c9\u897f\u90e8\u30c0\u30de\u30f3\u3067\u958b\u50ac\u3055\u308c\u305f\u7b2c23\u56de\u30a4\u30f3\u30c9\u982d\u9838\u90e8\u816b\u760d\u5b66\u4f1a\u7dcf\u4f1a\uff08The 23<\/span>rd<\/sup> National Conference of Foundation for Head and Neck Oncology\uff0f\u4ee5\u4e0b\u3001FHNO 2023\uff09\u306b\u304a\u3044\u3066\u3001\u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u6cbb\u7642\uff08\u5149\u514d\u75ab\u7642\u6cd5\uff0f\u4ee5\u4e0b\u3001\u672c\u6cbb\u7642\uff09\u306e\u5b9f\u81e8\u5e8a\u3067\u306e\u5b9f\u65bd\u7d4c\u9a13\u304c\u8c4a\u5bcc\u3067\u672c\u6cbb\u7642\u306e\u3055\u3089\u306a\u308b\u767a\u5c55\u306b\u5411\u3051\u305f\u7814\u7a76\u3067\u3082\u5b9f\u7e3e\u306e\u3042\u308b2\u540d\u306e\u533b\u5e2b\u304c\u65e5\u672c\u304b\u3089\u62db\u5f85\u3055\u308c\u3001\u4e09\u3064\u306e\u8b1b\u6f14\u304c\u884c\u308f\u308c\u307e\u3057\u305f\u306e\u3067\u3001\u304a\u77e5\u3089\u305b\u3057\u307e\u3059\u3002\u8b1b\u6f14\u6982\u8981\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/span><\/p>\n

FHNO 2023\u3067\u306e\u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u6cbb\u7642\u306b\u95a2\u3059\u308b\u62db\u5f85\u8b1b\u6f14\u306e\u6982\u8981\uff083\u6f14\u984c\uff09<\/b><\/span><\/p>\n

\u6f14\u984c\u540d: Photoimmunotherapy for Lower Gingival Cancer
\n<\/b>\u767a\u8868\u8005: \u897f\u5ddd\u5927\u8f14 \u533b\u5e2b\uff08\u611b\u77e5\u770c\u304c\u3093\u30bb\u30f3\u30bf\u30fc \u982d\u9838\u90e8\u5916\u79d1\u90e8\uff09
\n<\/b>\u30bb\u30c3\u30b7\u30e7\u30f3\u540d: INVITED VIDEOS
\n<\/span>\u65e5\u6642: 2023\u5e7412\u670822\u65e5<\/span> \u5348\u524d8:00-9:00\uff08\u3046\u30615\u5206\uff09
\n<\/span>\u653e\u5c04\u7dda\u6cbb\u7642\u6b74\u3092\u6709\u3059\u308b\u4e0b\u984e\u6b6f\u8089\u304c\u3093\u60a3\u8005\u306b\u5bfe\u3057\u3066\u672c\u6cbb\u7642\u3092\u884c\u3063\u305f\u30b1\u30fc\u30b9\u3092\u5b9f\u4f8b\u3068\u3057\u3066\u793a\u3057\u3001\u672c\u6cbb\u7642\u306e\u5b9f\u81e8\u5e8a\u306b\u304a\u3051\u308b\u60a3\u8005\u9078\u629e\u306e\u8003\u3048\u65b9\u304a\u3088\u3073\u30cb\u30fc\u30c9\u30eb\u7a7f\u523a\u3084\u5149\u7167\u5c04\u306a\u3069\u306e\u6cbb\u7642\u624b\u6280\u306b\u3064\u3044\u3066\u52d5\u753b\u3067\u8aac\u660e\u3057\u305f\u3002\u307e\u305f\u3001\u8853\u5f8c\u306b\u767a\u73fe\u3057\u305f\u6d6e\u816b\u3078\u306e\u5bfe\u5fdc\u3084\u3001\u816b\u760d\u7e2e\u5c0f\u306b\u4f34\u3044\u767a\u73fe\u3057\u305f\u763b\u5b54\u306e\u6642\u9593\u7d4c\u904e\u306a\u3069\u3001\u6709\u5bb3\u4e8b\u8c61\u306e\u7ba1\u7406\u306b\u3064\u3044\u3066\u3082\u7d39\u4ecb\u3057\u305f\u3002<\/span><\/p>\n

\u6f14\u984c\u540d: Photoimmunotherapy for Recurrent Head and Neck Cancers - Japanese experience
\n<\/b>\u767a\u8868\u8005: \u897f\u5ddd\u5927\u8f14 \u533b\u5e2b\uff08\u611b\u77e5\u770c\u304c\u3093\u30bb\u30f3\u30bf\u30fc \u982d\u9838\u90e8\u5916\u79d1\u90e8\uff09
\n<\/b>\u30bb\u30c3\u30b7\u30e7\u30f3\u540d: RECURRENT & METASTATIC DZ
\n<\/span>\u65e5\u6642: 2023\u5e7412\u670822\u65e5<\/span> \u5348\u5f8c3:00-4:30\uff08\u3046\u306115\u5206\uff09
\n<\/span>\u672c\u6cbb\u7642\u306e\u75c7\u4f8b\u7d39\u4ecb\u3092\u4e2d\u5fc3\u3068\u3057\u305f\u5b9f\u81e8\u5e8a\u3067\u306e\u6cbb\u7642\u6210\u7e3e\u3068\u5b89\u5168\u6027\u306b\u95a2\u3059\u308b\u60c5\u5831\u3001\u514d\u75ab\u5fdc\u7b54\u306b\u95a2\u3059\u308b\u63a2\u7d22\u7684\u7814\u7a76\u7d50\u679c\u306a\u3069\u3092\u7d39\u4ecb\u3057\u305f\u3002\u611b\u77e5\u770c\u304c\u3093\u30bb\u30f3\u30bf\u30fc\u30672021\u5e74\uff11\u6708\uff5e2023\u5e7412\u6708\u306b15\u4eba\u306e\u60a3\u8005\u306b\u5b9f\u65bd\u3057\u305f26\u56de\u306e\u6cbb\u7642\u3067\u306f\u3001\u6982\u306d\u826f\u597d\u306a\u6cbb\u7642\u6210\u7e3e\u304c\u5f97\u3089\u308c\u305f\u3002\u307e\u305f\u3001\u540c\u30bb\u30f3\u30bf\u30fc\u30675\u4eba\u306e\u60a3\u8005\u306b\u5b9f\u65bd\u3057\u305f7\u56de\u306e\u6cbb\u7642\u306b\u304a\u3044\u3066\u3001\u6cbb\u7642\u5f8c\u306e\u672b\u68a2\u8840\u3067\u514d\u75ab\u5fdc\u7b54\u3092\u793a\u5506\u3059\u308bdamage-associated molecular patterns\uff08DAMPs\uff09\u306e\u653e\u51fa\u3084\u30b1\u30e2\u30ab\u30a4\u30f3\u306e\u7523\u751f\u304c\u78ba\u8a8d\u3055\u308c\u3001\u672c\u6cbb\u7642\u306b\u3088\u308a\u514d\u75ab\u539f\u6027\u7d30\u80de\u6b7b\u304c\u30d2\u30c8\u306b\u304a\u3044\u3066\u3082\u8a98\u5c0e\u3067\u304d\u308b\u53ef\u80fd\u6027\u304c\u793a\u3055\u308c\u305f<\/span>1<\/sup>\u3002\u672c\u6cbb\u7642\u306f\u3001\u73fe\u5728\u3001\u75bc\u75db\u30fb\u6d6e\u816b\u30fb\u763b\u5b54\u30fb\u5149\u7dda\u904e\u654f\u75c7\u306a\u3069\u306e\u6709\u5bb3\u4e8b\u8c61\u306b\u5bfe\u3059\u308b\u7279\u5225\u306a\u914d\u616e\u306e\u3082\u3068\u3001\u518d\u767a\u982d\u9838\u90e8\u304c\u3093\u306b\u5bfe\u3059\u308b\u5c40\u6240\u6cbb\u7642\u306e\u6700\u5f8c\u306e\u6cbb\u7642\u9078\u629e\u80a2\u3068\u3057\u3066\u5b9f\u65bd\u3055\u308c\u3066\u3044\u308b\u3002<\/span><\/p>\n

\u6f14\u984c\u540d: Near-infrared Photoimmunotherapy: Translational research and clinical application
\n<\/b>\u767a\u8868\u8005: \u5ca1\u7530\u9686\u5e73 \u533b\u5e2b\uff08\u6771\u4eac\u533b\u79d1\u6b6f\u79d1\u5927\u5b66\u75c5\u9662 \u982d\u9838\u90e8\u5916\u79d1\uff09
\n<\/b>\u30bb\u30c3\u30b7\u30e7\u30f3\u540d: DR SUDHIR BAHADUR SCIENCE SYMPOSIUM
\n<\/span>\u65e5\u6642: 2023\u5e7412\u670824\u65e5<\/span> \u5348\u524d8:30-9:30\uff08\u3046\u306115\u5206\uff09
\n<\/span>\u5b9f\u81e8\u5e8a\u306b\u304a\u3044\u3066EGFR\u3092\u6a19\u7684\u3068\u3057\u305f\u672c\u6cbb\u7642\u3092\u4e0b\u54bd\u982d\u304c\u3093\u306b\u5b9f\u65bd\u3057\u305f\u75c7\u4f8b\u3067\u306f\u3001\uff14\u56de\u306e\u6cbb\u7642\u3092\u53d7\u3051\u308b\u4e2d\u3067\u816b\u760d\u306e\u7e2e\u5c0f\u304c\u78ba\u8a8d\u3055\u308c\u305f\u3053\u3068\u3001\u6700\u7d42\u7684\u306b\u75c5\u72b6\u9032\u884c\u3068\u8a3a\u65ad\u3055\u308c\u305f\u304c\u3001\uff11\u5e74\u9593\u306f\u672c\u6cbb\u7642\u306e\u307f\u3067\u75c5\u72b6\u3092\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3067\u304d\u305f\u3053\u3068\u306a\u3069\u3092\u7d39\u4ecb\u3057\u305f\u3002\u6cbb\u7642\u6210\u7e3e\u306e\u3055\u3089\u306a\u308b\u5411\u4e0a\u306e\u305f\u3081\u306b\u884c\u3063\u305f\u975e\u81e8\u5e8a\u7814\u7a76\u306e\u30c7\u30fc\u30bf\u3082\u7d39\u4ecb\u3057\u305f\u3002\u6297PD-1\u6297\u4f53\u3068\u816b\u760d\u7d30\u80de\u3092\u6a19\u7684\u3068\u3059\u308b\u5149\u514d\u75ab\u7642\u6cd5\uff08PIT\uff09\u3068\u306e\u4f75\u7528\u306b\u95a2\u3059\u308b\u30de\u30a6\u30b9\u3067\u306e\u7814\u7a76\u306b\u304a\u3044\u3066\u3001\u4f75\u7528\u7fa4\u3067\u306f\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u7fa4\u3084\u5358\u72ec\u6cbb\u7642\u7fa4\u3068\u6bd4\u3079\u3066\u816b\u760d\u5897\u6b96\u306e\u6709\u610f\u306a\u6291\u5236\u3068\u751f\u5b58\u671f\u9593\u306e\u6709\u610f\u306a\u5ef6\u9577\u304c\u78ba\u8a8d\u3055\u308c\u305f<\/span>2<\/sup>\u3002\u307e\u305f\u3001CD25\u3092\u6a19\u7684\u3068\u3059\u308bPIT\u306b\u3088\u308a\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u5185\u306eTreg\u3092\u5c40\u6240\u7684\u306b\u6392\u9664\u3059\u308b\u3053\u3068\u3067\u3001\u514d\u75ab\u7cfb\u306e\u6d3b\u6027\u5316\u3092\u793a\u5506\u3059\u308b\u30a8\u30d5\u30a7\u30af\u30bf\u30fc\u7d30\u80de\u306e\u6025\u6fc0\u306a\u6d3b\u6027\u5316\u304c\u78ba\u8a8d\u3055\u308c\u308b\u3068\u3068\u3082\u306b\u3001\u30a2\u30d6\u30b9\u30b3\u30d1\u30eb\u52b9\u679c\u3082\u78ba\u8a8d\u3055\u308c\u305f<\/span>3<\/sup>\u3002CTLA4\u3092\u6a19\u7684\u3068\u3057\u305fPIT\u304c\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u5185\u306eTreg\u3092\u5c40\u6240\u7684\u306b\u6392\u9664\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u6297\u816b\u760d\u52b9\u679c\u304c\u5f97\u3089\u308c\u308b\u3053\u3068\u3084<\/span>4<\/sup>\u3001EGFR\u3068CD25\u306e\u4e8c\u3064\u3092\u6a19\u7684\u3068\u3059\u308bPIT\u304c\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u7fa4\u3084\u5358\u72ec\u6cbb\u7642\u7fa4\u3068\u6bd4\u3079\u3066\u816b\u760d\u5897\u6b96\u3092\u6709\u610f\u306b\u6291\u5236\u3059\u308b\u3053\u3068<\/span>5<\/sup>\u3082\u3001\u975e\u81e8\u5e8a\u30c7\u30fc\u30bf\u3067\u78ba\u8a8d\u3055\u308c\u305f\u3002<\/span><\/p>\n<\/div>\n<\/div><\/div><\/div><\/div>

\n
\n\t\t\"\"\n\t<\/div>\n\n

\u897f\u5ddd\u5148\u751f\u306e\u8b1b\u6f14<\/h3><\/div><\/div><\/div>
\n
\n\t\t\"\"\n\t<\/div>\n\n

\u5ca1\u7530\u5148\u751f\u306e\u8b1b\u6f14<\/h3><\/div><\/div><\/div><\/div>
\n
\n\t\t\"\"\n\t<\/div>\n\n

\u897f\u5ddd\u5148\u751f<\/h3><\/div><\/div><\/div>
\n
\n\t\t\"\"\n\t<\/div>\n\n

\u5ca1\u7530\u5148\u751f\uff08\u5de6\uff09<\/h3><\/div><\/div><\/div><\/div>
\n
\n\t

\u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u72ec\u81ea\u306e\u6280\u8853\u57fa\u76e4\u3067\u3042\u308b\u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u2122\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u57fa\u306b\u958b\u767a\u3055\u308c\u305f\u6700\u521d\u306e\u533b\u85ac\u54c1\u300c\u30a2\u30ad\u30e3\u30eb\u30c3\u30af\u30b9<\/span>\u00ae<\/span>\u70b9\u6ef4\u9759\u6ce8250\u338e\u300d\uff08\u958b\u767a\u30b3\u30fc\u30c9\uff1aASP-1929\uff09\u304a\u3088\u3073\u533b\u7642\u6a5f\u5668\u30ec\u30fc\u30b6\u88c5\u7f6e\u300cBioBlade<\/span>\u00ae<\/span>\u30ec\u30fc\u30b6\u30b7\u30b9\u30c6\u30e0\u300d\u3092\u7528\u3044\u305f\u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u6cbb\u7642\u306f\u30012020\u5e749\u6708\u3001\u4e16\u754c\u306b\u5148\u99c6\u3051\u3066\u65e5\u672c\u306b\u304a\u3044\u3066\u300c\u5207\u9664\u4e0d\u80fd\u306a\u5c40\u6240\u9032\u884c\u53c8\u306f\u5c40\u6240\u518d\u767a\u306e\u982d\u9838\u90e8\u764c\u300d\u3092\u52b9\u80fd\u307e\u305f\u306f\u52b9\u679c\u3068\u3059\u308b\u88fd\u9020\u8ca9\u58f2\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u307e\u3057\u305f\u30022021\u5e741\u6708\u306e\u4e21\u88fd\u54c1\u767a\u58f2\u4ee5\u964d\u30013\u5e74\u9593\u3067400\u56de\u4ee5\u4e0a\uff082023\u5e7412\u6708\u672b\u6642\u70b9\uff09\u306e\u6cbb\u7642\u304c\u5b9f\u65bd\u3055\u308c\u3001\u982d\u9838\u90e8\u304c\u3093\u306e\u9769\u65b0\u7684\u306a\u6cbb\u7642\u9078\u629e\u80a2\u3068\u3057\u3066\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/span><\/p>\n

ASP-1929\u3092\u7528\u3044\u305f\u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u6cbb\u7642\u306f\u3001\u7c73\u56fd\u3001\u30a4\u30f3\u30c9\u3001\u53f0\u6e7e\u306a\u3069\u306e\u56fd\u30fb\u5730\u57df\u3067\u5c40\u6240\u518d\u767a\u982d\u9838\u90e8\u6241\u5e73\u4e0a\u76ae\u304c\u3093\u306b\u5bfe\u3059\u308b\u56fd\u969b\u5171\u540c\u7b2c\u2162\u76f8\u81e8\u5e8a\u8a66\u9a13\uff08ASP-1929-301\u8a66\u9a13\u3001ClinicalTrials.gov Identifier: <\/span>NCT03769506<\/span><\/a>\u3001CTRI Identifier\uff1a<\/span>CTRI\/2023\/05\/052728<\/span><\/a>\uff09\u304c\u9032\u884c\u4e2d\u3067\u3059\u3002\u30a4\u30f3\u30c9\u3067\u306f\u30012023\u5e748\u6708\u306bASP-1929-301\u8a66\u9a13\u306e\u767b\u9332\u60a3\u8005\u3078\u306e\u6cbb\u7642\u3092\u958b\u59cb\u3057\u307e\u3057\u305f\u3002\u8a73\u7d30\u306f\u30d7\u30ec\u30b9\u30ea\u30ea\u30fc\u30b9<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/span><\/p>\n

FHNO 2023\u306eOrganizing Chairman\u3067\u3042\u308a\u3001Kailash Cancer Hospital and Research Center\u306b\u304a\u3051\u308bASP-1929-301\u8a66\u9a13\u306e\u6cbb\u9a13\u8cac\u4efb\u533b\u5e2b\u3067\u3042\u308bRajesh A Kantharia, M.D.\u306f\u3001\u4ee5\u4e0b\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u4e21\u533b\u5e2b\u306bFHNO 2023\u306b\u304a\u8d8a\u3057\u3044\u305f\u3060\u304d\u3001\u3053\u306e\u753b\u671f\u7684\u6cbb\u7642\u6cd5\u306b\u3064\u3044\u3066\u30a4\u30f3\u30c9\u56fd\u5185\u306e\u591a\u304f\u306e\u982d\u9838\u90e8\u304c\u3093\u6cbb\u7642\u533b\u306b\u3054\u7d39\u4ecb\u3044\u305f\u3060\u3051\u305f\u3053\u3068\u3092\u5b09\u3057\u304f\u601d\u3044\u307e\u3059\u3002\u591a\u304f\u306e\u56fd\u6c11\u304c\u82e6\u3057\u3093\u3067\u3044\u308b\u982d\u9838\u90e8\u304c\u3093\u3078\u306e\u5bfe\u5fdc\u306f\u3001\u6211\u304c\u56fd\u6700\u5927\u306e\u533b\u7642\u8ab2\u984c\u306e\u4e00\u3064\u3067\u3059\u3002\u5149\u514d\u75ab\u7642\u6cd5\u306f\u3001\u816b\u760d\u306a\u3069\u306e\u6a19\u7684\u306b\u5bfe\u3057\u3066\u975e\u5e38\u306b\u9078\u629e\u7684\u3067\u3042\u308b\u3060\u3051\u3067\u306a\u304f\u3001\u5358\u72ec\u6cbb\u7642\u30fb\u4f75\u7528\u7642\u6cd5\u3044\u305a\u308c\u306b\u304a\u3044\u3066\u3082\u591a\u304f\u306e\u7814\u7a76\u304c\u9032\u3081\u3089\u308c\u3066\u304a\u308a\u3001\u9032\u5316\u3057\u7d9a\u3051\u308b\u3053\u306e\u6cbb\u7642\u6280\u8853\u306b\u5927\u304d\u306a\u53ef\u80fd\u6027\u3092\u611f\u3058\u3066\u3044\u307e\u3059\u3002\u30a4\u30f3\u30c9\u306b\u304a\u3044\u3066\u3082ASP-1929-301\u8a66\u9a13\u306e\u6cbb\u7642\u304c\u59cb\u307e\u308a\u307e\u3057\u305f\u3002\u3053\u306e\u6cbb\u7642\u6cd5\u304c\u3001\u672c\u56fd\u306e\u982d\u9838\u90e8\u304c\u3093\u6cbb\u7642\u3092\u5411\u4e0a\u3055\u305b\u3066\u304f\u308c\u308b\u3082\u306e\u3068\u671f\u5f85\u3057\u3066\u3044\u307e\u3059\u300d<\/span><\/p>\n<\/div>\n<\/div><\/div>

\n
\n\t\t\"\"\n\t<\/div>\n\n

Dr. Kantharia<\/h3><\/div><\/div>
\n
\n\t

 <\/p>\n

    \n
  1. Ishihara H, Nishikawa D, Muraoka D, et al. Changes in serum DAMPs and cytokines\/chemokines during near-infrared photoimmunotherapy for patients with head and neck cancer. Cancer Med. 2023; 00: 1-6. doi:<\/span>10.1002\/cam4.6863<\/span><\/a><\/span><\/li>\n
  2. Nagaya T, Friedman J, Maruoka Y, et al. Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors. Cancer Immunol Res. 2019;7(3):401-413. doi:<\/span>10.1158\/2326-6066.CIR-18-0546<\/span><\/a><\/span><\/li>\n
  3. Sato K, Sato N, Xu B, et al. Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy. Sci Transl Med. 2016;8(352):352ra110. doi:<\/span>10.1126\/scitranslmed.aaf6843<\/span><\/a><\/span><\/li>\n
  4. Okada R, Kato T, Furusawa A, et al. Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity. Adv Ther (Weinh). 2021;4(5):2000269. doi:<\/span>10.1002\/adtp.202000269<\/span><\/a><\/span><\/li>\n
  5. Okada R, Furusawa A, Vermeer DW, et al. Near-infrared photoimmunotherapy targeting human-EGFR in a mouse tumor model simulating current and future clinical trials. EBioMedicine. 2021;67:103345. doi:<\/span>10.1016\/j.ebiom.2021.103345<\/span><\/a><\/span><\/li>\n<\/ol>\n

     <\/p>\n<\/div>\n<\/div><\/div>

    \n
    \n\t

    \u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u793e\u306b\u3064\u3044\u3066<\/b><\/p>\n

    \u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u793e\u306f\u3001\u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u2122\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3068\u547c\u3076\u6280\u8853\u57fa\u76e4\u3092\u57fa\u306b\u3001\u85ac\u5264\u3068\u5149\u3092\u7d44\u307f\u5408\u308f\u305b\u305f\u3001\u304c\u3093\u3092\u306f\u3058\u3081\u3068\u3057\u305f\u69d8\u3005\u306a\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u3057\u3044\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u304a\u3088\u3073\u8ca9\u58f2\u3092\u884c\u3046\u30b0\u30ed\u30fc\u30d0\u30eb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3059\u3002\u540c\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u57fa\u306b\u958b\u767a\u3057\u305f\u533b\u85ac\u54c1\u30fb\u533b\u7642\u6a5f\u5668\u306e\u975e\u81e8\u5e8a\u8a66\u9a13\uff08\u975e\u516c\u958b\u30c7\u30fc\u30bf\uff09\u3067\u306f\u3001\u7279\u5b9a\u306e\u7d30\u80de\u306e\u9078\u629e\u7684\u306a\u58ca\u6b7b\u304c\u78ba\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u793e\u306f\u3001\u4e16\u754c\u4e2d\u306e\u4e00\u4eba\u3067\u3082\u591a\u304f\u306e\u60a3\u8005\u3055\u3093\u306b\u3001\u4e00\u65e5\u3067\u3082\u65e9\u304f\u3001\u79c1\u305f\u3061\u306e\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u3092\u304a\u5c4a\u3051\u3059\u308b\u3053\u3068\u306b\u3088\u308a\u300c\u30ac\u30f3\u514b\u670d\u3002\u300d\u3068\u3044\u3046\u30df\u30c3\u30b7\u30e7\u30f3\u306e\u5b9f\u73fe\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\u672c\u793e\u304c\u3042\u308b\u7c73\u56fd\u306b\u52a0\u3048\u3001\u65e5\u672c\u3001\u53f0\u6e7e\u3001\u30b9\u30a4\u30b9\u3001\u30a4\u30f3\u30c9\u306e\u4e16\u754c5\u30ab\u56fd\u306b\u62e0\u70b9\u3092\u6709\u3057\u3066\u3044\u307e\u3059\u3002\u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u682a\u5f0f\u4f1a\u793e\u306f\u3001\u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u793e\uff08\u7c73\u56fd\u6cd5\u4eba\uff09\u306e\u65e5\u672c\u6cd5\u4eba\u3067\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<\/span>https:\/\/rakuten-med.com\/jp\/<\/span><\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/span><\/p>\n

    \u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u2122\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u3064\u3044\u3066<\/b>\u00a0<\/span><\/p>\n

    \u30a2\u30eb\u30df\u30ce\u30c3\u30af\u30b9\u2122\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u6cbb\u7642\u6280\u8853\u57fa\u76e4\u306e\u540d\u79f0\u3067\u3042\u308a\u3001\u7c73\u56fd\u56fd\u7acb\u304c\u3093\u7814\u7a76\u6240\u306e\u5c0f\u6797\u4e45\u9686\u5148\u751f\u3089\u304c\u958b\u767a\u3057\u305f\u304c\u3093\u5149\u514d\u75ab\u7642\u6cd5\u304c\u57fa\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u540c\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u533b\u85ac\u54c1\u3001\u533b\u7642\u6a5f\u5668\u3001\u533b\u7642\u6280\u8853\u3001\u305d\u306e\u4ed6\u5468\u8fba\u6280\u8853\u3092\u7dcf\u5408\u7684\u306b\u5229\u7528\u3057\u305f\u6280\u8853\u57fa\u76e4\u3067\u3042\u308a\u3001\u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u793e\u306f\u3001\u3053\u308c\u306b\u57fa\u3065\u304d\u88fd\u54c1\u3084\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u3092\u9032\u3081\u3066\u3044\u307e\u3059\u3002\u540c\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3092\u7528\u3044\u305f\u6cbb\u7642\u306f\u3001\u300c\u85ac\u5264\u306e\u6295\u4e0e\u300d\u3068\u300c\u5149\u306e\u7167\u5c04\u300d\u306e 2 \u6bb5\u968e\u3067\u69cb\u6210\u3055\u308c\u307e\u3059\u3002\u85ac\u5264\u306f\u3001\u5149\u611f\u53d7\u6027\u7269\u8cea (\u5149\u306b\u53cd\u5fdc\u3059\u308b\u7269\u8cea) \u3068\u3001\u30ad\u30e3\u30ea\u30a2 (\u7279\u5b9a\u306e\u7d30\u80de\u306b\u9078\u629e\u7684\u306b\u96c6\u7a4d\u3059\u308b\u6210\u5206) \u304b\u3089\u7d44\u6210\u3055\u308c\u308b\u8907\u5408\u4f53\u3067\u3059\u3002\u540c\u85ac\u5264\u3092\u6295\u4e0e\u3057\u3001\u7279\u5b9a\u306e\u7d30\u80de\u306b\u9078\u629e\u7684\u306b\u96c6\u7a4d\u3055\u305b\u305f\u5f8c\u3001\u305d\u306e\u7d30\u80de\u306b\u7279\u5b9a\u306e\u5149\u3092\u7167\u5c04\u3059\u308b\u3053\u3068\u3067\u5149\u611f\u53d7\u6027\u7269\u8cea\u3092\u6d3b\u6027\u5316\u3055\u305b\u3001\u751f\u5316\u5b66\u30fb\u7269\u7406\u5b66\u7684\u30d7\u30ed\u30bb\u30b9\u306b\u3088\u308a\u3001\u7279\u5b9a\u306e\u7d30\u80de\u3092\u58ca\u6b7b\u3055\u305b\u3001\u3042\u308b\u3044\u306f\u3001\u6392\u9664\u3057\u307e\u3059\u3002<\/span><\/p>\n<\/div>\n<\/div><\/div>

    \n\t\t\t\n\t\t\n\t\t\t\n\t\t\t\u304a\u554f\u3044\u5408\u308f\u305b\u306f\u3053\u3061\u3089\t\t<\/span>\n\t\t\t<\/a>\n\t<\/div>\n<\/div><\/div><\/div>